Sustained Release Pellets for Controlled Dosage

Sustained Release (SR) Pellets for Global Pharma Needs

At Credo Life Sciences, we specialize in the manufacturing of high-quality Sustained Release (SR) pellets designed to meet the evolving needs of the global pharmaceutical industry. Our SR pellets are developed with superior dissolution profiles, consistent release kinetics, and customizable formulations that adhere to stringent international regulatory standards including EU, SFDA, WHO guidelines.

About SR Products

Our Sustained Release (SR) pellets are advanced multiparticulate dosage forms developed to provide controlled and predictable drug release over an extended period. By regulating the release rate of active pharmaceutical ingredients (APIs), our SR pellets help maintain steady plasma concentrations, ensuring consistent therapeutic outcomes and improved patient safety.

We design SR pellets with a strong focus on patient convenience and compliance. By reducing dosing frequency and minimizing drug plasma fluctuations, these formulations not only enhance bioavailability but also lower the risk of adverse effects. This makes them ideal for a wide range of therapeutic applications, from cardiovascular and central nervous system treatments to gastrointestinal and anti-infective therapies.

To achieve the highest level of performance, we utilize cutting-edge manufacturing technologies such as extrusion–spheronization, fluid bed coating, and advanced polymer layering techniques. These processes ensure uniform particle size distribution, excellent flow properties, and robust mechanical stability, delivering consistent quality that aligns with global regulatory standards.

Key Features

Controlled Release Profiles

Formulated to maintain integrity and effectiveness during storage.

Versatile APIs

Manufactured under strict GMP and international compliance norms.

Regulatory Compliance

Uniform drug release ensuring reliable bioavailability

Customizable Formulations

Tailored solutions to meet diverse therapeutic needs.

High Stability & Uniformity

Engineered with precision technology for improved therapeutic outcomes

Scalability & Supply Capability

Optimized formulation ensures better absorption and therapeutic efficiency.

SR Product Portfolio

Product Name	Percentage Available	Therapeutic Usage
Aceclofenac	60%	Anti-inflammatory
Cinitapride	1.45%	GI Motility Agent
Domperidone	17% / 20% / 22% / 30%	Anti-emetic
Galantamine	8%	Alzheimer’s Treatment
Indomethacin	27.5%	Anti-inflammatory
Itopride	60%	GI Motility Agent
Ketoprofen	70%	Anti-inflammatory
Mebeverine HCI	80%	Anti-spasmodic
Nifedipine	10%	Anti-hypertensive
Nitroglycerin	1.4%, 2.5%	Anti-anginal
Tamsulosin + Dutasteride	0.4 mg + 0.5 mg	BPH Treatment
Tamsulosin HCL	0.12% / 0.133% / 0.14% / 0.16% / 0.20%	BPH Treatment
Venlafaxine HCI	33%, 50%	Anti-depressant